A phase I single and multiple ascending dose trial of PQ 912 in healthy volunteers

Trial Profile

A phase I single and multiple ascending dose trial of PQ 912 in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Jul 2013

At a glance

  • Drugs PQ 912 (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Jul 2013 Results presented at the Alzheimer's Association International Conference, according to a Probiodrug media release.
    • 07 Mar 2013 Final results were presented at the The 11th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2013)
    • 16 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top